Latent Tuberculosis Infection

**62**

*Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex*

[11] Dean AS, et al. Epidemiology of Drug-Resistant Tuberculosis. Strain Variation in the *Mycobacterium* 

*tuberculosis* Complex: Its Role in Biology, Epidemiology and Control. pp. 209-22

[12] WORLD HEALTH ORGANIZATION:

[13] Pan American Health Organisation. Tuberculosis in the Americas 2018. Pan American Health Organisation; Washington, DC, USA: 2018. WHO., DOI: 10.1080/23802359.2018.1483754

[14] Battista Migliori G, et al. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Curr Opin Pulm Med 16:171-179, DOI: 10.2471/BLT.14.030514

[15] Tengan FM, et al. Prevalence of multidrug-resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta-analysis. Europen Journal of Tropic & Intern Health, Volume 25, Issue 9; September 2020.

[16] CDC. Fact Sheet: TB Drug Resistance

[17] Millet J, et al. A First Assessment of *Mycobacterium tuberculosis* Genetic Diversity and Drug-Resistance Patterns in Twelve Caribbean Territories. Biomed Research Intern. Volume 2014 |Article

[18] Bergonzoli G, et al. Determinants of tuberculosis in countries of Latin America and the Caribbean. Rev Panam

Salud Publica 39(2), 2016

ID 718496

in the U.S. ww.cdc.gov/nchhstp/ newsroom/docs/factsheets/tb-drugresistance-factsheet.pdf. Published October 2015. Accessed June 19, 2017

TUBERCULOSIS

[1] Maiolini M, et al. The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives. Molecules. 2020 Jul; 25(13): 3011

[2] Cantres-Fonseca O, et al. Extra Pulmonary Tuberculosis: An Overview. Role of Microbes in Human Health and

[3] Iseman MD. Tuberculosis therapy: past, present and future. European Respiratory Journal. 2002; 20: 87S-94s, DOI: 10.1177/0022219410391190

[4] WHO: Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients. May 2016

[5] Woodman M, et al. Tuberculosis Genetic Epidemiology: A Latin American Perspective. Genes (Basel).

[6] Lallungawi J, et al. Drug resistant Tuberculosis: A review. Comparative Immun Microb and Infect Dis 74.

[7] Kerantzas CA, et al. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. Am Soc for Microbiol; March/April 2017 Volume

[8] Kurz SG, et al. Drug Resistant Tuberculosis: Challenges and Progress. Infect Dis Clin North Am. 2016 Jun;

[9] Singh A, et al. Drug-Resistant

Tuberculosis and HIV Infection: Current Perspectives. HIV AIDS (Auckl). 2020; 12: 9-31, DOI: 10.2147/HIV.S193059.

[10] Zhao J, et al. Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China. PLoS One. 2015; 10(8): e0135205, DOI: 10.1371/journal.pone.0135205.

8 Issue 2 e01586–e01516

30(2): 509-522.

2019 Jan; 10(1): 53.

Sept 2020.

Disease. Intech Open 2019.

**References**

**65**

**Chapter 5**

of Life

**Abstract**

*Dinara Namazovna Adjablaeva*

Latent Tuberculous Infection:

Influence on Patient's Quality

Latent tuberculosis infection is an asymptomatic condition in which patients carry the bacteria, but do not show any sign of illness, however they are at risk of disease activation at any time in the future. Understanding of influence of latent tuberculosis infection on the physical and mental well-being of these patients is important as successful strategies to reduce the tuberculosis burden globally. Our purpose is to explore patients during diagnosis and treatment of latent tuberculosis infection, measure their quality of life. Materials and methods: during 2017–2019 was examined 100 children 4–7 years age. Children were divided in 3 groups. First group (n = 40) - a children with LTI. Group of the comparison (n = 40) has comprised preschool age children with tuberculosis. Group of the checking (n = 20) have constituted the preschool age healthy children. Estimation of children health was conducted by analysis health factors: social, genetic, biological. In addition were studied criteria of health. It was used study anamnestic data, questioning, estimation quality of life, anthropometry, data of objective examination, laboratory data and parameters of functioning, electrocardiography, vegetative nervous system spectrography (VNS-spectrography), manual ergometry. Physical development valued with the help of specialized tables. Leukocyte intoxication index is calculated on formula Shemitova V.F. Variety heart rhythm (VHR) was studied by method VNS-spectrography on vegetotester "VNS-Micro" with computer program "Polispectr" of company "Neyrosoft". Interpretation source vegetative tone and vegetative reactivity was realized according to recommendation N.A. Belokon. Vegetative provision of activity was valued on tolerance to steady-state load by method manual ergometry (MEM) in help of manual dynamometer. Quality of life was defined with the help of questionnaire PedsQL version 4.0 (the Russian version). Results and their discussion: in children with active tuberculosis, specific process has a most negative influence upon quality of life, comparatively temporary negative influence has LTI. Revealed changes in general have brought to reduction of QL indicators both in first and second group. With provision of latency currents of infecting with mycobacteria of tuberculosis, indicators of quality of life should be considered as one of defining, reflecting psychological component adaptation of child, and can be recommended to enter in program of examination and dispensary observation of children with LTI. Conclusions: our study has shown that preschool age children with LTI have rather significant deflections of health condition, revealing by symptoms of intoxication, expressed breaches adaptation and regulation mechanisms. Results of study have logistical confirmed need of improvement of the preventive maintenance and dispensary observation at children with LTI and active
